Correlation Between Nutriband and Champions Oncology

Can any of the company-specific risk be diversified away by investing in both Nutriband and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nutriband and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nutriband and Champions Oncology, you can compare the effects of market volatilities on Nutriband and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nutriband with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nutriband and Champions Oncology.

Diversification Opportunities for Nutriband and Champions Oncology

0.22

Correlation Coefficient

Nutriband  Champions Oncology

Modest diversification

The 3 months correlation between Nutriband and Champions is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Nutriband and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Nutriband is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nutriband are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Nutriband i.e., Nutriband and Champions Oncology go up and down completely randomly.

Pair Corralation between Nutriband and Champions Oncology

Given the investment horizon of 90 days Nutriband is expected to generate 1.08 times less return on investment than Champions Oncology. In addition to that, Nutriband is 1.37 times more volatile than Champions Oncology. It trades about 0.02 of its total potential returns per unit of risk. Champions Oncology is currently generating about 0.03 per unit of volatility. If you would invest  418.00  in Champions Oncology on September 4, 2024 and sell it today you would earn a total of  13.00  from holding Champions Oncology or generate 3.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Nutriband  vs.  Champions Oncology

Nutriband

Risk-Adjusted Performance

1 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Nutriband are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nutriband may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Champions Oncology

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Nutriband and Champions Oncology

The main advantage of trading using opposite Nutriband and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nutriband position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.

The idea behind Nutriband and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.